Improving laboratory workforce efficiency using AI-assisted digital cytology within an HPV-based cervical screening programme: a model-based evaluation for the NHS Cervical Screening Programmes
Context Cervical screening aims to prevent cervical cancer in women and people with a cervix by identifying and treating cell changes before they develop into cancer. Within the NHS Cervical Screening Programmes in the UK, samples are first tested for high-risk human papillomavirus (HPV). Samples that test positive are then assessed using cytology to identify Read More >
Health economic evaluation of an mRNA HR-HPV assay versus a DNA HR-HPV assay for the proposed French cervical screening programme
User experience and workflow performance: a pilot evaluation of the Genius Digital Diagnostics System for screening cervical cytology samples
A health economic model to estimate the costs and benefits of an mRNA vs DNA high-risk HPV assay in a hypothetical HPV primary screening algorithm in Ontario, Canada
Evaluating the benefits and costs of using an mRNA versus DNA HR-HPV assay in the National Cervical Screening Programme in the Netherlands
Modelling the impact of using a DNA compared to mRNA HPV assay as part of the cervical screening programmes in Sweden and Denmark
Estimating the costs and benefits of HR-HPV assay choice in a theoretical HPV primary cervical screening algorithm in Ontario, Canada
Evaluating the choice of HPV assay in the French cervical screening programme with a decision tree model
Modelling the choice of high-risk human papillomavirus (HR-HPV) assay in the English cervical screening programme
